A chemical cleavage method for detecting mismatched bases in heteroduplexes formed between patient mRNA and control cDNA probes was employed to identify a single base mutation in a heterozygous case of osteogenesis imperfecta type IV. The parents' fibroblast mRNA did not contain the mutation. The region of the mRNA mismatch was amplified by using the polymerase chain reaction, cloned and sequenced. A point mutation of G to U at base-pair 2162 of the collagen a2(I) mRNA resulted in the substitution of glycine by valine at amino acid position 586 of the helix. This substitution disrupted the critical Gly-Xaa-Yaa repeating unit of the collagen triple helix and resulted in helix destabilization, as evidenced by a decreased thermal stability. This local disturbance to helix propagation from the Cterminus to the N-terminus led to the overmodification of the collagen helix downstream towards the N-terminus. However, collagen secretion in vitro was normal, and the clinical phenotype probably resulted from the secretion into the extracellular matrix of the mutant collagen combined with a decrease in collagen production to 65 % of control values. The rapid detection of the osteogenesis imperfecta mutation by using the chemical cleavage method afforded the opportunity to apply the technique to prenatal diagnosis in the next pregnancy of the mother of the osteogenesis imperfecta patient. The absence of a mismatched base in chorionic villus mRNA and control cDNA heteroduplexes indicated that the foetus did not carry the mutation, which was confirmed by the subsequent delivery of a normal baby.
INTRODUCTION
Osteogenesis imperfecta (01) is a heritable connective-tissue disorder in which bone fragility is the main clinical manifestation (Cole, 1988; Byers, 1989) . There are four main clinical types, and mutations of type I collagen have been identified in each (Sillence et al., 1979; Prockop & Kivirikko, 1984; Cheah, 1985; Byers, 1990) . The mutations include point mutations, insertions, deletions and re-arrangements in the COLJAJ gene that codes for the pro-al(I) gene that codes for the pro-al(I) chain and in the COLIA2 gene that codes for the pro-al(I) chain of type I collagen (reviewed by Byers, 1990) .
Many of the mutations result in the substitution of glycine residues within the large triple-helical domain of the a-chains. Glycine residues normally occupy each third position and are essential for the correct formation of the triple helix. Patients with glycine substitutions towards the C-terminus of the helix of the al(I) chain are likely to be more clinically severe than those with substitutions towards the N-terminus (Byers, 1990; Starman et al., 1989) . However, the type of a-chain involved, the nature and site of the substitution and the surrounding sequence may also contribute to the severity of the phenotype.
The proposal has been made that glycine substitutions in the a2(I) chain lead to a milder phenotype than equivalent substitutions in the al(I) chain because of the stoichiometry of type I collagen molecules. In the usual heterozygous state found in OI, mutations of the a2(I) chain would be expected to result in equal proportions of normal and mutant molecules, as type I collagen molecules contain only one a2(I) chain. As type I collagen contains two al(I) chains, heterozygous mutations of this chain would be expected to result in only 25 % normal molecules, as 75 % of them would contain one or two mutant chains. The prediction of a milder phenotype with substitutions in the ac2(I) chain is supported by the substitution of Gly-1012 by arginine at the junction of the helix and the C-telopeptide of the a2(I) chain in a moderately severe form of 01, classified as OI-IV (Wenstrup et al., 1988) . However, the proposal is challenged by reports of helical substitutions of Gly-865 by serine and of Gly-907 by aspartic acid in lethal perinatal OI Baldwin et al., 1989) . (Amino acid positions are numbered by the standard convention in which the first glycine residue of the triple-helical domain of the a-chain is number 1.)
In the present paper we report the substitution of Gly-586 by valine in the a(2(I) chain of type I collagen in a child with a moderately severe form of OI, classified as type IV-B.
EXPERIMENTAL Clinical summary
The female child, 0150, had a progressively deforming type of OI with dentinogenesis imperfecta. As the parents were clinically normal and unrelated, she was classified as having OI type IV-B (Sillence et al., 1979; Cole, 1988; Byers, 1989) . Bone tissue was obtained from the patient and controls during routine orthopaedic procedures. Dermal fibroblast cultures were established from the parents and the patient, and a chorionic villus biopsy was undertaken for intra-uterine diagnosis at 11 weeks in the following pregnancy. All tissue biopsies were obtained with informed consent and approval of the Ethics Committee of this hospital. Fibroblast cultures established from the dermis and chorionic villus were maintained as described previously (Bateman et al., 1984 (Bateman et al., , 1986 . Extraction of bone coliagens Bone samples were freeze-milled and decalcified as previously described (Bateman et al., 1986) . Limited pepsin digestion was carried out, and the solubilized collagens were analysed by gel electrophoresis.
Abbreviation used: 01, osteogenesis imperfecta.
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Labelling of fibroblast coliagens Procollagens were biosynthetically labelled in confluent fibroblast cultures (Bateman et al., 1984 (Bateman et al., , 1986 (Bateman et al., 1984 (Bateman et al., , 1986 .
SDS/PAGE
Collagen a-chains were resolved on 5 % (w/v) separating gels containing 2 M-urea (Bateman et al., 1984 (Bateman et al., , 1986 . Collagens prepared from cell cultures and tissues were also digested with CNBr and analysed by electrophoresis on 12.5 % (w/v) gels (Scott & Veis, 1976; Bateman et al., 1987b) . The a-chains and peptides were detected by fluorography (Bonner & Laskey, 1974) or staining with Coomassie Brilliant Blue (Cole & Bean, 1979) .
Thermal stability of collagen
The freeze-dried [3H]proline-labelled collagens were dissolved in 0.4 M-NaCl/0.1 M-Tris/HCl buffer, pH 7.4, at 4 'C. The samples were warmed stepwise (1 'C/min) from 34 'C to 43 'C and, at 0.5 'C intervals, samples were taken and digested with a mixture of trypsin and chymotrypsin as described by Bruckner & Prockop (1981) . The proportion of the collagen that was resistant to proteolysis at each temperature interval was determined by scintillation counting of the radioactivity of collagen a-chain bands that were resolved by electrophoresis and identified by fluorography (Bateman et al., 1988b) . The thermal denaturation temperature, Tm, was defined as the temperature at which half of the collagen was degraded.
Formation and chemical cleavage of mRNA . cDNA heteroduplexes Total RNA was isolated from confluent fibroblast cultures (Lui et al., 1979; Wake & Mercer, 1985) . mRNA * cDNA heteroduplexes were formed in a volume of 50,1 containing approx. 5 ng (50000-100000 d.p.m.) of labelled cDNA probe, 5-10 /ug of total RNA, 80% (v/v) formamide, 40 mM-Pipes buffer, pH 6.4, 1 mM-EDTA and 0.4 M-NaCl. The mixture was denatured at 80 'C for 5 min, incubated at 60 'C for 2 h and precipitated with ethanol. Chemical modification of mismatched nucleotides with hydroxylamine or osmium tetroxide, cleavage with piperidine and electrophoresis of the products on denaturing 7 M-urea/5 % acrylamide gels have been described previously (Cotton et al., 1988; Dahl et al., 1989; Lamande et al., 1989; Bateman et al., 1989) .
The apparent site of the mutation in the collagen chains was used as a guide to the selection of suitable control cDNAs for heteroduplex formation. Control al(I) and a2(I) cDNA probes, chosen to span the abnormal region, were purified and endlabelled with [a-32P] dCTP by the fill-in reaction using the Klenow fragment of DNA polymerase I (Sambrook et al., 1989 [The base-pairs are numbered from the start of transcription of the pro-a2(I) mRNA (de Wet et al., 1987) .] Approx. 50 ng of cDNA was amplified by the PCR (Saiki et al., 1988) through 30 cycles with the use of Taq polymerase (Perkin-Elmer-Cetus) (Kogan et al., 1987) . Each cycle consisted of denaturation at 92°C for 1.5 min, annealing of primers at 62°C for 1.5 min and primer extension at 72°C for 3 min Bateman et al., 1989) . A 371 bp fragment corresponding to bases 1984-2355 of the a2(I) cDNA was amplified with the primers 5'-CCTGATGGAAACAAGGGTGA-3' and 5'-TTCTCCTTTAGCACCCGGTT-3' (de Wet et al., 1987) . Amplification products of the predicted size were purified, treated with T4 polynucleotide kinase (Sambrook et al., 1989) and cloned into a SmaI-cut dephosphorylated Ml3mp8 vector (Amersham Corp.) . Multiple clones from two independent amplification reactions were sequenced by using a Sequenase kit (United States Biochemical Corp.).
RESULTS

Protein abnormalities
Abnormally slow electrophoretic mobilities of the al(I) and a2(I) chains were observed in type I collagen extracted from 0150 bone (results not shown). This migrational abnormality was also evident in labelled collagen from the cell layer and medium of cultured 0150 fibroblasts (Fig. 1, lane 2) . In contrast, the collagen a-chains produced by fibroblasts from both parents migrated normally (Fig. 1, lanes 3 and 4) . Type I collagen secretion by OI50 fibroblasts was apparently normal (Bateman et al., 1988a) .
The slow migration of the 0150 a-chains was probably due to overmodification of lysine residues on the N-terminal side of the mutation (Bateman et al., 1984 (Bateman et al., , 1986 (Fig. 2) , suggesting that the mutation causing helix perturbation and consequent overmodification of lysine residues was in the central region of either the a2(I) or al(I) chain. There were no apparent abnormalities in type III or V collagens (results not shown).
Detection of an abnormal mRNA sequence by chemical cleavage Heteroduplexes were formed with control a2(I) and aI1(I) cDNAs, which spanned the central portion of the collagen helix, and mRNA extracted from cultured dermal fibroblasts of OI50 and controls. Hydroxylamine/piperidine treatment cleaved a 300 bp fragment from the 910 bp NcoI-XhoI fragment of a2(I) cDNA. This finding suggested that there was a mismatched C at approximately base-pair 2161 of the control cDNA (Fig. 3) . Treatment with osmium tetroxide/piperidine did not reveal any T mismatches (Fig. 3) . No mismatches were detected by hydroxylamine or osmium tetroxide treatment of heteroduplexes formed between OI50 mRNA and control ocl(I) cDNA (results not shown).
Characterization of the mRNA mutation
The chemical cleavage method of detecting sequence mismatches defined the position and the mismatched base in the control a2(I) cDNA probe but did not define the precise base change in the mutant mRNA. To define the mutation, a short length of first-strand a2(I) cDNA was amplified by the PCR with unique oligonucleotides chosen to span the region containing the mismatch.
Sequencing of M13 subclones of the amplified products identified the mutation as a single base substitution that converted the codon for glycine (GGT), at position 586 of the helix, into GTT (valine) (Fig. 4) containing the normal sequence (GGT) were also identified, indicating that the patient was heterozygous for the a2(I) mutation.
The codon for amino acid 588 of the triple-helical domain of the a2(I) chain was CCT (proline) in the normal and mutant amplified cDNAs of OI50 as well as in control cDNAs, rather than the published codon, CAT (histidine) (de Wet et al., 1987) .
Melting temperature of collagen
The thermal denaturation temperature (Tm) of type I collagen synthesized by OI50 and control fibroblasts was estimated by measuring its resistance to proteinase digestion after heating to different temperatures (Fig. 5) 
normal al(I) trimer molecules have increased levels of posttranslational modifications (Uitto, 1979) , prenatal diagnosis by detection of slow migration of the a-chains due to underlying structural defects was not possible.
However, since the cells produced ax2(I) mRNA, the chemical cleavage method of detecting point mutations could be used collagen population contained a significant proportion of al(I) homotrimeric molecules as well as heterotrimeric type I collagen molecules with the normal chain composition, [al(I)]2a2(I). Since A heterozygous point mutation of G to T was identified at position 2162 of the a2(I) cDNA in this case of OI type IV-B. The deduced amino acid change consisted of the substitution of Gly-586 by valine in the a2(I) chain of type I collagen. It probably represented a new sporadic mutation in the patient as neither parent had clinical evidence of 01 or evidence of the mutation in dermal fibroblasts. Mosaicism in one parent, which has been described in 01 Wallis et al., 1990) , was not excluded.
Our previous studies showed that type I collagen production was reduced to about 65 % of control values, although the proportion secreted was normal (Bateman et al., 1988a) . Electrophoretic analysis of the a-chains and CNBr-cleavage peptides was not able to detect directly the substitution of Gly-586 by valine, but indirect evidence of the mutation was found. The evidence consisted of the slow migration of all the a-chains and selected CNBr-cleavage peptides of type I collagen. The slow migration of the a-chains was likely to be due to enzymic overmodification of lysine residues on the N-terminal side of the glycine substitution (Bateman et al., 1984; Bonadio & Byers, 1985) . As the child was heterozygous for the mutation, we Fig. 3 (see the Experimental section for details). The labelled .2(I) cDNA fragment was cleaved at a reactive C by hydroxylamine (300 bp) in 0150 (see Fig. 3 ) whereas the heteroduplex formed with parental or foetal mRNA remained uncleaved, indicating that the 0150 mutation was not carried by the parents or by the foetus. The molecular-mass standards used were 32P-labelled HaelII fragments of qSX174 DNA. expected that about half the molecules would contain a mutant a2(I) chain and be overmodified while the remaining molecules would be normal. The explanation for the discrepancy between the observed and expected results was not determined. However, similar discrepancies have also been observed in some of the OI patients with glycine substitutions in the al(I) chain, where only slowly migrating collagen was identified (Bateman et al., 1984 (Bateman et al., , 1986 , although the patients were heterozygous and expressed normal as well as mutant alleles (Bateman et al., 1987a; Lamande et al., 1989) . The functional consequences of glycine substitutions in any of the repeating Gly-Xaa-Yaa triplets of the helical domain of the a-chains may depend on the type of a-chain involved, the nature and site of the substitution and the surrounding sequence. The glycine substitution in 0150 had a relatively small helix-destabilizing effect. In 0150, the thermal stability was reduced by 0.8°C, whereas reductions of 1-1.5°C were usual with glycine substitutions in the al(I) chain (Baker et al., 1989 The sequence surrounding the glycine substitution may have also contributed to the small helix-destabilizing effect. The local sequence around a2(I) Gly-586 contains only one potentially hydroxylatable proline residue at position 588. The corresponding region of the al(I) chain is also largely devoid of hydroxylatable proline residues and thus this region of the type I collagen helix may be relatively 'loose', as hydroxyproline residues stabilize the helix (Burjanadze, 1979) . This 'looseness' of the normal helix may mean that the substitution of Gly-586 has a less disruptive effect than if it occurred in a different region of the a2(I) chain. Three babies with mutations resulting in the substitution of glycine by valine in the helical domain of al(I) chains have been reported Patterson et al., 1989) . They were lethal perinatal cases of OI (OI-II) with substitution of Gly-1006, Gly-973 or Gly-256. The baby with the more N-terminal substitution survived longer than the other babies, which may indicate that a gradient of clinical severity exists from the Cterminal substitution to more N-terminal one. A gradient of clinical severity, from lethal OI-II cases to mild OI-I cases, has also been reported for substitutions of glycine by cysteine in the helix of the al(I) chain (Starman et al., 1989) .
Too few glycine substitutions have been reported in the a2(I) chain to be able to make any useful correlations between the site and type of a2(I) substitutions and their phenotypic consequences. However, the identification of glycine substitutions in patients with type II and type IV OI suggests that a similar range of phenotypes to those found with al(I) substitutions will be found. Further studies should help to reveal functionally important domains within the type I collagen al(I) and a2(I) chains.
Intra-uterine diagnosis was successfully undertaken in the subsequent pregnancy. When we undertook these studies, we had localized the sequence abnormality in a2(I) mRNA, using the chemical cleavage method of detecting sequence mismatches in mRNA cDNA heteroduplexes, but we had not sequenced the mutation. As a result, the chemical cleavage method was used to screen directly for the mutation in foetal a2(I) mRNA obtained from cultured chorionic villus cells. The absence of an abnormal cleavage product from the foetal sample indicated that the foetus did not carry the mutation. The use of the chemical cleavage method for prenatal diagnosis was much more definitive than protein analysis on chorionic villus cells. Protein analyses rely on the indirect assessment of the mutation by abnormal electrophoretic migration, and, in this case, the presence of slowly migrating al trimer molecules made interpretation of the result ambiguous. Thus the chemical cleavage method represents a convenient diagnostic strategy when a mismatch has been identified in the previously affected individual. In many cases this may also prove to be a preferable strategy to the alternative molecular approaches of PCR amplification of the region containing the mutation followed by sequencing or allele-specific restriction mapping.
